💊
Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau)
chenodeoxycholic acid
Xanthomatose, cérébrentineuse; Métabolisme, erreurs innées
✅ Autorisé
✅
Aucune alerte active
Ce médicament ne fait l'objet ni de pénuries en cours, ni de lettres de sécurité, ni de rappels.
À quoi ça sert
Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.
⚠️ Sécurité des patients
No
Page officielle de l'EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/chenodeoxycholic-acid-leadiant